Who are Fluconazole and Secnidazole's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/fluconazole-and-secnidazole.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Fluconazole and Secnidazole — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Fluconazole and Secnidazole (Fluconazole and Secnidazole) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antifungal/antiprotozoal combination. Area: Infectious Disease.

phase 3 Antifungal/antiprotozoal combination Fungal CYP51 (lanosterol 14α-demethylase); protozoal DNA Infectious Disease Small molecule Live · refreshed every 30 min

Target snapshot

Fluconazole and Secnidazole (Fluconazole and Secnidazole) — Universidad Nacional de Colombia. Fluconazole and secnidazole is a combination antifungal and antiprotozoal agent that inhibits fungal ergosterol synthesis and disrupts protozoal DNA, respectively.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Fluconazole and Secnidazole TARGET	Fluconazole and Secnidazole	Universidad Nacional de Colombia	phase 3	Antifungal/antiprotozoal combination	Fungal CYP51 (lanosterol 14α-demethylase); protozoal DNA

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antifungal/antiprotozoal combination class)

Universidad Nacional de Colombia · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Fluconazole and Secnidazole — Competitive Intelligence Brief. https://druglandscape.com/ci/fluconazole-and-secnidazole. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab